134
Participants
Start Date
January 31, 2005
Primary Completion Date
November 30, 2012
Study Completion Date
November 30, 2012
Doxil
Starting dose of 20 mg/m\^2 IV over 2 hours on Day 1, 21 day cycle
Gemcitabine
500 mg/m\^2 IV over 30 minutes on Days 1 and 8, 21 day cycle
Velcade
Starting dose of 0.7 mg/m\^2 IV on Days 1 and 8 of first 21 day cycle; increased dose of 1.0 to 1.3 on Days 1, 4, 8, and 11 of subsequent 21 day cycles
UT MD Anderson Cancer Center, Houston
M.D. Anderson Cancer Center
OTHER